Skip to main content
. 2021 Aug 20;12(20):5991–5998. doi: 10.7150/jca.61310

Figure 2.

Figure 2

VOAV, FNAV or RFAV inhibited gastric cancer cell proliferation in vitro. (A) The growth inhibitory effect of VOAV, FNAV or RFAV was measured using the CCK-8 assay. MFC cells were treated with varying concentrations of VOAV, FNAV or RFAV (from 25 to 100 µg/mL for 24 h). (B) MFC cells were treated with VOAV, FNAV or RFAV at 25 µg/mL for 96 h. *0.01 < p < 0.05, **0.001 < p < 0.01, ***p <0.001 were considered statistically significant difference from control.